Urinary Tract Infections in Solid Organ Transplantation
Abstract
Infections remain a major cause of morbidity and mortality in transplant recipients. Since the pattern of infections change continually due to evolving donor–recipient characteristics, surgical techniques and immunosuppression regimens, a periodic review of this subject and recommendation for its evaluation and treatment is essential. Infections account for 16% of patient deaths and 7.7% (14% in patients >65 years of age) of death censored graft failure in kidney transplant (KT) recipients (1,2).
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.